Behavioral and Psychosocial Characteristics of Clients Accessing Services at IHRI

The Institute of HIV Research and Innovation (IHRI)

This protocol describes a 20-year prospective cohort study, gathering behavioral and psychosocial information on clients who access services of the Institute of HIV Research and Innovation (IHRI) and the Thai Red Cross AIDS Research Centre through the Thai Red Cross Anonymous Clinic, the Thai Red Cross Mobile Clinics, Affiliated Health Clinics, The gender and immunity clinic and Pribta Tangerine Polyclinic. Services provided through these sites include VCT, STD screening and treatment, anal and cervical Pap smears, general health checkups, sexual health education, and sexual health communication, gender-affirmative hormone therapy (GAHT) and risk-reduction via web boards and chat rooms.

Behavioral and psychosocial information will be collected using validated questionnaires and from data collection forms routinely used when providing services in different service sites of IHRI and the TRC-ARC. The information will be collected anonymously at baseline and at follow-up visits, according to type of services each client receives. Clients at the Thai Red Cross Anonymous Clinic, Thai Red Cross Mobile Health Clinics, Affiliated Health Clinics and Pribta Tangerine Polyclinic will be given an identification number.

Qualitative methods, including focus group discussions (FGD) and in-depth interviews (IDI) will be conducted with clients and healthcare providers to examine the facilitators, barriers, feasibility and acceptability of service implementation.

Study Overview

Detailed Description

STUDY OBJECTIVES

  1. To describe behavioral and psychosocial characteristics of clients who access services.
  2. To understand the effectiveness of the HIV prevention package offered to clients who access services in terms of cost and infections averted
  3. To study changes in behavioral and psychosocial characteristics among clients over time
  4. To study differences in behavioral and psychosocial characteristics among clients by gender identity, sexual orientation, HIV status, and service sites
  5. To assess behavioral and psychosocial factors that influence the willingness to participate in study trials
  6. To assess the facilitators, barriers, feasibility and acceptability of and satisfaction with service implementation among clients and healthcare providers under IHRI and TRCARC

Study Type

Observational

Enrollment (Estimated)

300000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Rena Janamnuaysook, MBA
  • Phone Number: 6698 516 4562
  • Email: rena.j@ihri.org

Study Contact Backup

Study Locations

    • Bangkok
      • Pathum Wan, Bangkok, Thailand, 10330
        • Recruiting
        • Tangerine Clinic, Institute of HIV Research and Innovation
        • Contact:
        • Contact:
          • Rena Janamnuaysook, MBA
          • Phone Number: +66 2 1605371
          • Email: rena.j@ihri.org

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Study population: Clients accessing services of the Pribta Tangerine Polyclinic, the Thai Red Cross Anonymous Clinic, the Thai Red Cross Mobile Clinics and Affiliated Health Clinics.

Description

Inclusion Criteria:

  1. 18 years or 16 and 17 years of age with parental or guardian consent In non- or pre-SRS cases
  2. Recommendation1 by counsellor based on:

    A) Presence of GD history B) Understanding of risks and benefits of GAHT D) Practice and readiness for gender transition E) Availability of social support F) Ability to take hormones as instructed

  3. Verbal informed consent or signed informed consent on file
  4. No exclusionary medical conditions
  5. Approved by physician

In SRS- and post-SRS cases2

  1. Verbal informed consent or signed informed consent on file
  2. No exclusionary medical conditions
  3. Approved by physician

Exclusion Criteria:

None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Primary Outcome Measure
Time Frame: 20 years
  1. Demographic characteristics
  2. Social and sexual behaviors
  3. Psychosocial characteristics
  4. Clinical characteristics
  5. Referral and linkage to care for HIV-positive clients
  6. Characteristics associated with service implementation
20 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Siriporn Nonenoy, BNH,MPH, Institute of HIV Research and Innovation

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 2, 2013

Primary Completion (Estimated)

July 2, 2030

Study Completion (Estimated)

July 2, 2035

Study Registration Dates

First Submitted

December 12, 2024

First Submitted That Met QC Criteria

December 16, 2024

First Posted (Actual)

December 18, 2024

Study Record Updates

Last Update Posted (Actual)

April 2, 2026

Last Update Submitted That Met QC Criteria

March 29, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on HIV

Clinical Trials on Demographic characteristics

Subscribe